Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Making major improvements over current standard of care – how does this new treatment work? The FDA recently approved a new indication for a product that has been used...
College Diabetes Network’s free “Off to College” booklets on overcoming diabetes challenges during the college transition
Glucose, food, exercise, and even DIY closed loop on the phone
Patients with high A1c levels could achieve greater blood glucose control from the start.
A1c cannot capture the whole picture – hypoglycemia, time in range, and quality of life add so much more!
Data from Bluetooth-enabled meter can now be shared with other health tracking apps.
How will this expansion help tackle urban diabetes worldwide?
Close 12-11 vote in favor of label update. Plus, nearly 40% reduction in kidney disease shown at ADA.
less risk of diabetes complications, lower A1c, improved weight loss and hypoglycemia; led by Novo Nordisk’s Victoza and semaglutide
Revolution Foods, Plum Organics, and Kurbo Health: resources to bring nutrition education and meals to children in need.
The First Lady’s ongoing initiatives to improve children’s nutrition, health, and wellbeing
Abbott’s free Android app for caregivers is now available
Bigger calorie type font, addition of added sugar, larger portion sizes, and more! First Lady Michelle Obama announced recently at the Partnership for a Healthier...
Brings real-time insulin tracking, history, and a bolus calculator to injectors; launch in 2017
Renowned pediatric endocrinologist offers a lens into what it means to be a caregiver.
People with type 2 diabetes should contact their physicians if symptoms of heart failure appear.
Significant Improvement in A1c and time-in-range when adding CGM.
Approaching the conversation, words and phrases to use, and more!
80 days, 5 lbs of weight loss, and my strongest blood glucose numbers ever?
MannKind has re-launched the inhaled mealtime insulin, Afrezza, alongside new initiatives to promote the product

Pages